Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Pharmacology|January 1, 1985
Protein binding and disposition of lignocaine in the elderlyB Cusack, K O'Malley, J Lavan, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|February 10, 2000
Analysis of binding sites and efficacy of a species-specific peptide at rat and human neurotensin receptorsB Cusack, T Chou, K Jansen, et al.
Molecular Pharmacology|November 1, 1993
Pharmacological studies on novel neurotensin mimetics: discovery of a pharmacologically unique agent exhibiting concentration-dependent dual effects as antagonist and agonistB Cusack, E Richelson, Y P Pang, et al.
Brain Research|June 24, 1998
Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociceptionB M Tyler, B Cusack, C L Douglas, et al.
Journal of Computer-Aided Molecular Design|August 1, 1994
Rational design of novel neurotensin mimetics: discovery of a pharmacologically unprecedented agent exhibiting concentration-dependent dual effects as antagonist and full agonistY P Pang, J Zaidi, A P Kozikowski, et al.
Clinical Pharmacology and Therapeutics|June 1, 1979
Digoxin in the elderly: pharmacokinetic consequences of old ageB Cusack, J Kelly, K O'Malley, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 24, 1998
Refined radiation hybrid map of mouse chromosome 17L C Schalkwyk, M Weiher, M Kirby, et al.
Brain Research|May 18, 2000
A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodentsM Boules, B Cusack, L Zhao, et al.
Biochemical Pharmacology|August 10, 2000
A single amino acid of the human and rat neurotensin receptors (subtype 1) determining the pharmacological profile of a species-selective neurotensin agonistB Cusack, K Jansen, D J McCormick, et al.
Brain Research|March 10, 2000
Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidolB Cusack, M Boules, B M Tyler, et al.
Pageof 5